Update on Evidence of CALGB 30406 Trial: Chemo/EGFR Inhibitor vs. EGFR Inhibitor Alone in Never-Smokers
Article
Just prior to ASCO, I mentioned the early results of the Cancer and Leurkemia Group B (CALGB -- Group A long-since defunct) 30406 trial.